WASHINGTON, D.C. – A top Pfizer executive was caught on camera sprinting away from a reporter representing Project Veritas who was asking her about the pharmaceutical giant’s alleged cover-up of the use of fetal cells in vaccine development. The video is the latest entry in the controversial undercover group’s ongoing series examining the background of the COVID-19 vaccine.
Project Veritas raised eyebrows with a recent video featuring a Pfizer whistleblower – who has since been terminated from the company – and produced emails between top executives in the company discussing how to minimize the degree to which fetal cell lines derived from aborted fetuses were used in the development phase of the vaccine.
While fetal cell lines may be used to develop or manufacture COVID-19 vaccines, the vaccines themselves do not contain any aborted fetal cells. According to a Los Angeles County Department of Public Health document, pharmaceutical companies prefer human cell lines over other cells for a variety of reasons including that viruses tend to grow better in cells from humans than animals.
A Project Veritas reporter encountered Pfizer’s Senior Director of Worldwide Research, Vanessa Gelman, on the street in Washington D.C. and attempted to conduct an on-camera interview with her. However, before the reporter could even finish introducing himself, Gelman – appearing shocked and alarmed – took-off down the street. The reporter is seen chasing after her while inquiring about Pfizer’s use of fetal cells in vaccine development, until she finally reaches what appears to be her home and locks herself inside.
Big Tech is using NewsGuard to censor us severely reducing our revenue. You can support our mission of truthful reporting by making a contribution. Honest journalism is incredibly important to our democracy; we refuse to let Silicon Valley crush us into just another regurgitated, propaganda driven, echo-chamber of lamestream media and we need your support. You can also help by signing up for our featured story emails.
Gelman was one of the executives featured in Pfizer emails produced by the company’s whistleblower, where she purportedly discussed with another executive what she perceived as the negative aspects of sharing information on the development of their vaccine with the public.
“We want to avoid having information on the fetal cells floating out there,” the email from Gelman allegedly said. “We believe that the risk of communicating this right now outweighs any potential benefit we could see, particularly with general members of the public who may take this information and use it in ways we may not want it out there.”